Login / Signup

High proportion of anergic B cells in the bone marrow defined phenotypically by CD21(-/low)/CD38- expression predicts poor survival in diffuse large B cell lymphoma.

Sewa RijalJohanna KokCaitlin CoombesLillian SmythJayde HouriganSanjiv JainDipti Talaulikar
Published in: BMC cancer (2020)
High proportion of anergic B cells in the BM characterized by CD21(-/low)/CD38- expression predicts poor survival outcomes in DLBCL.
Keyphrases
  • diffuse large b cell lymphoma
  • bone marrow
  • poor prognosis
  • epstein barr virus
  • binding protein
  • free survival